skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

8 Total results for product and free and sample content found

Medtech Insight

Boston Scientific Divests Specialty Pharma Business

By Reed Miller 08 Dec 2020

Boston Scientific Pharma

The $800m sale of BTG Specialty Pharmaceuticals business to SERB leaves Boston Scientific with BTG’s successful interventional oncology and vascular products.

Topic M A Market Intelligence

Scrip

Amid New M&A Rumors, Amarin CEO Focused On Vascepa Approval

By Andrew McConaghie 27 Nov 2020

Article

John Thero insists company is focused on approval and launch, as interest in European rights grow.

Topic Cardiovascular M A

Biomedtracker

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

By Daniel Chancellor 27 Nov 2020

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

Topic M A

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 17 Nov 2020

Scrip August Podcast

Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.

Topic Coronavirus M A

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 28 Aug 2020

Scrip August Podcast

Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical sector. 

Topic Coronavirus M A

In Vivo

In Vivo Deal Making Article Pack

15 Apr 2020

In Vivo Deal Making Article Pack

Gain a view into the market gaps, opportunities, and trends in biopharma with a look at deal-making from In Vivo. Examine how deal-making has impacted the industry and shifted market dynamics and learn how you can use knowledge of these trends to inform your own strategies.

Topic M A Deals

Scrip

Big pharma results through acquisition and divestment?

10 Mar 2020

Big pharma results through acquisition and divestment?

Go behind the headlines from Big Pharma’s year-end conferences for insights into the most significant recent M&A and divestment activities. Scrip takes you inside the strategies of pharma’s leading companies as they enter a new decade.

Topic M A

Scrip

J.P. Morgan 2020: What To Watch For At The Industry's Biggest Meeting

By Jessica Merrill 08 Jan 2020

JP_Morgan_2020_What_To_Watch

The J.P. Morgan Healthcare conference is being held a week later than usual, which only makes us more ready to hear what the industry's leaders have in store. Here's a preview of potential hot topics.

Topic Deals Leadership M A

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: